Abstract
We have analysed the cell-cycle arrests and cytotoxicity of the A2780 human ovarian cell line in response to geldanamycin, a benzoquinoid ansamycin that can inhibit tyrosine kinases. Geldanamycin causes a dose-dependent G2 arrest and reversible inhibition of entry into the S phase in A2780 cells. After a 3-h exposure to 0.1 µM geldanamycin, the cells show an increase in accumulation of p53 protein that is maximal at 24 h after drug exposure. Increased p53 levels can be induced in cells by DNA-damaging agents; however, using alkaline elution and sister chromatid exchange assays we detect no DNA damage induced by geldanamycin. Using dominant negative mutant TP53 transfectants of A2780 we have analysed the possible dependence of geldanamycin-induced cell-cycle arrests on the presence of functional p53. We observe no difference in cell-cycle arrests in mutant p53 transfectants known to have the p53-DNA damage-response pathway inactivated as compared with vector-alone controls. Similarly, we observe no difference in clonogenic resistance to the cytotoxicity of geldanamycin in these cells. These results suggest that geldanamycin can induce increased p53 protein by a mechanism not involving DNA damage. Furthermore, the cell-cycle arrests and cytotoxic effects of geldanamycin in these cells are not mediated by p53-dependent pathways.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baker SJ, Markowitz S, Fearon ER, Wilson JKV, Vogelstein B (1990) Suppression of human colorectal carcinoma cell growth by wild type p53. Science 249:912
Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Lonie KG, Knutsen T, McKoy WM, Young RC, Ozols RF (1987) Characterisation of a cis-diamminedichloroplatinum II resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res 47:414
Benchekroun MN, Schneider E, Safa AR, Townsend AJ, Sinha BK (1994) Mechanisms of resistance to ansamycin antibiotics in human breast cancer cell lines. Mol Pharmacol 46:677
Brown R, Clugston C, Burns P, Edlin A, Vasey P, Vojtesek B, Kaye SB (1993) Increased accumulation of p53 in cisplatinresistant ovarian cell linesInt J Cancer 55:678
Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849
Fritsche M, Haessler C, Brandner G (1993) Induction of nuclear accumulation of the tumour-suppressor protein p53 by DNA-damaging agents. Oncogene 8:307
Garcia R, Parikh NU, Saya H, Gallick GE (1991) Effect of herbimycin A on growth and pp60c-src activity in human colon tumour cell lines. Oncogene 6:1983
Girinsky T, Graeber TG, Tsai M, Giaccia AJ (1994) Effect of tyrosine kinase inhibitors on p53 protein induction in wild-type and human papillomavirus E6 expressing cells. Proc Am Assoc Cancer Res 35:642
Jacobson MD, Burne JF, Raff MC (1994) Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 13:1899
Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304
Kelland LR, Mistry P, Abel G, Loh SY, O’Neill CF, Murrer BA, Harrap KR (1992) Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates. Cancer Res 52:3857
Khanna KK, Lavin MF (1993) Ionising radiation and UV induction of p53 protein by different pathways in ataxia-telan-giectasia cells. Oncogene 8:3307
Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89:7491
Lin D, Shields MT, Ullrich SJ, Appella E, Mercer WE (1992) Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. Proc Natl Acad Sci USA 89:9210
Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957
McIlwrath AJ, Vasey PA, Ross GM, Brown R (1994) Cell cycle arrests and radiosensitivity of human tumour cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res 54:3718
Milner J, Medcalf EA, Cook AC (1991) Tumour suppressor p53 analysis of wild-type and mutant p53 complexes. Mol Cell Biol 11:12
Nelson WG, Kastan MB (1994) DNA strand breaks: the DNA template alterations that trigger p53-dependent-DNA damage response pathways. Mol Cell Biol 14:1815
O’Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I, Kohn KW (1993) Role of the p53 tumour suppressor gene in cell cycle arrest and radiosensitivity of Burkitt’s lymphoma cell lines. Cancer Res 53:4776
Perry P, Wolff S (1974) New Geimsa method for the differential staining of sister chromatids. Nature 251:156
Sherr CJ (1993) Mammalian Gl cyclins. Cell 73:1059
Takahashi K, Suzuki K, Uehara Y, Ono T (1995) Growth inhibition by anchorage deficiency is associated with increased level but reduced phosphorylation of mutant p53. Jpn J Cancer Res 83:358
Uehara Y, Hori M, Takeuchi T, Umezawa H (1985) Screening of agents which convert ‘transformed morphology’: identification of an active agent as herbimycin and its inhibition of intracellular src kinase. Jpn J Cancer Res 76:672
Uehara Y, Hori M, Takeuchi T, Umezawa H (1986) Phenotypic change from transformed to normal induced by benzoquinoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus. Mol Cell Biol 6:2198
Uehara Y, Fukazawa H, Murakami Y, Mizuno S (1989) Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds. Biochem Biophys Res Commun 163:803
Wyke AW, Cushley W, Wyke JA (1993) Mitogenesis by v-src: a need for active oncoprotein both in leaving GO and in completing G1 phases of the cell cycle. Cell Growth Differ 4:671
Yamaki H, Suzuki H, Choi EC (1982) Inhibition of DNA synthesis in murine tumour cells by geldanamycin, an antibiotic of the benzoquinoid ansamycin group. Antibiot 35:886
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McIlwrath, A.J., Brunton, V.G. & Brown, R. Cell-cycle arrests and p53 accumulation induced by geldanamycin in human ovarian tumour cells. Cancer Chemother Pharmacol 37, 423–428 (1996). https://doi.org/10.1007/s002800050407
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s002800050407